)
)
Dancann Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Dancann Pharma
Access all reports
The company, through its subsidiary Kron Medical ApS, develops a portfolio of novel cannabinoid therapies on the basis of patented technology platforms in the areas of pain, cancer, and brain diseases/disorders. It is also developing medicines for the treatment of infantile spasms or seizures; and a class of drugs for the treatment of various conditions caused by redox signalling imbalance. The company was founded in 2015 and is based in Odense, Denmark
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
DANCAN
Country
🇩🇰 Denmark